Vimarsana
Biggest News Aggregation in the World

Page 9 - Dirk Neum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dirk Neum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dirk Neum Today - Breaking & Trending Today

EQS-News: Biotest AG: Biotest receives 'Innovation Champion of Sustainability' award - Vimarsana News

EQS-News: Biotest AG: Biotest receives 'Innovation Champion of Sustainability' award

EQS-News: Biotest AG / Key word(s): Miscellaneous Biotest AG: Biotest receives 'Innovation Champion of Sustainability' award 1...

Biotest AG: Biotest receives 'Innovation Champion of Sustainability' award - Vimarsana News

Biotest AG: Biotest receives 'Innovation Champion of Sustainability' award

EQS-News: Biotest AG / Key word(s): MiscellaneousBiotest AG: Biotest receives 'Innovation Champion of Sustainability' award 19.01.2023 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement. PRESS RELEASE   Biotest receives "Innovation Champion of Sustainability" awar...

EQS-News: Biotest AG: Biotest treats first COVID-19 patients with trimodulin in TRICOVID phase III trial - Vimarsana News

EQS-News: Biotest AG: Biotest treats first COVID-19 patients with trimodulin in TRICOVID phase III trial

EQS-News: Biotest AG / Key word(s): Study Biotest AG: Biotest treats first COVID-19 patients with trimodulin in TRICOVID phase III tr...

Biotest AG: Biotest treats first COVID-19 patients with trimodulin in TRICOVID phase III trial - Vimarsana News

Biotest AG: Biotest treats first COVID-19 patients with trimodulin in TRICOVID phase III trial

EQS-News: Biotest AG / Key word: Study Biotest AG: Biotest treats first COVID-19 patients with trimodulin in TRICOVID phase III trial 10.01.2023 / 07:00 CET/CEST The issuer is... | January 10, 2023

Biotest AG: First patient enrolled in phase II clinical trial for treatment of chronic hepatitis B w - Vimarsana News

Biotest AG: First patient enrolled in phase II clinical trial for treatment of chronic hepatitis B w

EQS-News: Biotest AG / Key word(s): StudyBiotest AG: First patient enrolled in phase II clinical trial for treatment of chronic hepatitis B with hyperimmunoglobulins 08.12.2022 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement. PRESS RELEASE   First patient enrolled in p...